132 related articles for article (PubMed ID: 37981866)
1. Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case.
Akman BT; Arıca D; Koca E; Karakuş S
J Oncol Pharm Pract; 2024 Apr; 30(3):605-609. PubMed ID: 37981866
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.
Afacan Ozturk HB; Albayrak M; Maral S; Reis Aras M; Yilmaz F; Akyol P; Tiglioglu M; Malkan UY
J Oncol Pharm Pract; 2021 Dec; 27(8):2027-2029. PubMed ID: 33847196
[TBL] [Abstract][Full Text] [Related]
3. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
Hisatake J; Shimozuma J
Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
Bennett MT; Sirrs S; Yeung JK; Smith CA
Leuk Lymphoma; 2005 Dec; 46(12):1829-31. PubMed ID: 16263588
[TBL] [Abstract][Full Text] [Related]
5. Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
Atas U; Aydin Ersoy M; Iltar U; Yucel OK; Turkoglu EB; Salim O
J Oncol Pharm Pract; 2022 Sep; 28(6):1474-1477. PubMed ID: 35088649
[TBL] [Abstract][Full Text] [Related]
6. Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia.
Vanier KL; Mattiussi AJ; Johnston DL
J Pediatr Hematol Oncol; 2003 May; 25(5):403-4. PubMed ID: 12759628
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
Sakakibara M; Ichikawa M; Amano Y; Matsuzawa S; Agematsu K; Mori T; Koike K; Nakahata T; Komiyama A
Leuk Res; 1993 May; 17(5):441-3. PubMed ID: 8501972
[TBL] [Abstract][Full Text] [Related]
8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Cordoba R; Ramirez E; Lei SH; Lopez de la Guia A; Sanjurjo MJ; Carcas AJ; Hernandez-Navarro F
Eur J Clin Pharmacol; 2008 Oct; 64(10):1031-2. PubMed ID: 18584165
[No Abstract] [Full Text] [Related]
10. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
11. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Voriconazole on Metabolism of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia: A Case Report.
Hashmi Y; Memon SF; Khan YA; Jabbar N; Mansoor N
Cureus; 2021 Feb; 13(2):e13337. PubMed ID: 33747646
[TBL] [Abstract][Full Text] [Related]
13. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
14. A rare incidence of severe dermatological toxicities triggered by concomitant administration of all-trans retinoic acid and triazole antifungal in patients with acute promyelocytic leukemia: a case series and review of the literature.
Jamal A; Hassam R; Rizvi Q; Saleem A; Khalid A; Anwar N
J Med Case Rep; 2024 May; 18(1):261. PubMed ID: 38797854
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K
Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/day.
Lemez P
Eur J Haematol; 1995 Oct; 55(4):275-6. PubMed ID: 7589349
[No Abstract] [Full Text] [Related]
18. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG).
Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Sakamaki H; Tsubaki K; Saito K; Ohno R
Cancer Chemother Pharmacol; 1997; 40 Suppl():S30-5. PubMed ID: 9272131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
